申请人:Astra Aktiebolag
公开号:US05807886A1
公开(公告)日:1998-09-15
Compounds of the formula (I) ##STR1## wherein D represents a 5-membered heterocyclic aromatic ring containing 1 to 4 heteroatoms selected from O, N or S, optionally substituted at a carbon atom by halogen, trifluoromethyl, alkyl C1 to 6, nitro, cyano, and which is connected to the remainder of the compound of formula (I) through a carbon atom; A represents (N(X) or CH(--(CH.sub.2).sub.m --NXY); U represents NH, O or CH.sub.2 ; V represents (CH.sub.2).sub.b ; a, b,m, X and Y are as defined in the specification, together with processes for their preparation and compositions containing them. Compounds of formula (I) are nitric oxide synthetase inhibitors and are useful in therapy.
式(I)的化合物 ##STR1## 其中D代表含有1至4个来自O、N或S的杂原子的5元杂环芳香环,可选地在一个碳原子上被卤素、三氟甲基、烷基C1至C6、硝基、氰基取代,并且通过一个碳原子连接到式(I)化合物的其余部分;A代表(N(X)或CH(--(CH.sub.2).sub.m --NXY);U代表NH、O或CH.sub.2;V代表(CH.sub.2).sub.b;a、b、m、X和Y的定义如规范中所述,以及它们的制备方法和含有它们的组合物。式(I)的化合物是一氧化氮合酶抑制剂,可用于治疗。